USPTO serial 79454841
CERYVYN THERAPEUTICS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVOIE, RYAN CHRISTOPHER
- Law office
- TMEG LAW OFFICE 108
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with CERYVYN THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; chemical products for pharmaceutical use; chemicals for pharmaceutical use; pharmaceutical compositions; pharmaceutical creams; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations for animals; pharmaceutical preparations for human use; pharmaceutical preparations for personal use; pharmaceutical preparations for veterinary use; pharmaceutical products; pharmaceuticals; pharmaceutical products for use by humans; pharmaceutical substances; veterinary medicaments; veterinary preparations; veterinary products; biological preparations for medical purposes; biological preparations for use in biotechnology (medical); biological preparations for use in cell cultures (medical); biological preparations for veterinary purposes; biological products for medical use; biological reagents for use in molecular biology for medical and research purposes; biological substances for medical use; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; chemical products for use in biology (medical or veterinary use); therapeutic biological products (medical); medical preparations; substances for use in genetic probe assay kits (for medical use); substances for veterinary use produced by genetic engineering; cultures of cell media for medical use; cultures of cell media for veterinary use; chemical products for laboratory use (medical or veterinary); chemical analysers (preparations) for medical use; chemical preparations for medical analysis purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; chemical products for analysis (medical); chemical products for analysis (veterinary); chemical products for biotechnological purposes (medical); chemical products for biotechnological purposes (veterinary); chemical products for diagnostic purposes (medical or veterinary); chemical products for diagnostic use (medical); chemical products for diagnostic use (veterinary); chemical products for medical use; chemical products for use in medical science being chemical products for medical use; chemical products for use in science (medical or veterinary); chemicals for use in analysis (medical and veterinary); healthcare preparations and supplements; medicines. | ACTIVE | — |
| 042 | Advisory services relating to scientific research; laboratory services (scientific research or analysis); management of scientific research projects; medical research (scientific research for medical purposes); preparation of reports relating to scientific research; preparation of scientific reports; providing information, including online, about scientific and technological services and research and design relating thereto; provision of information relating to scientific research; provision of scientific information; scientific advisory services; scientific and technical analysis; scientific and technological services; scientific consultancy; scientific laboratory services; scientific research; scientific research in the field of pharmacy; scientific research into the development of new products; scientific research relating to bacteriology; scientific research relating to biology; scientific research relating to chemical products; scientific research relating to chemistry; scientific research relating to genetics; scientific testing services; bacteriological research; biochemistry research services; biological research; biotechnological research; biotechnology research; chemical research; chemical technological research; genetic research; laboratory research; medical research; pharmaceutical research services; providing information, including online, about industrial analysis and research services; provision of scientific research services; research and development of new products for others; research and development of products; research to develop new products; research laboratories; research relating to bacteriology; research relating to biotechnology; research relating to chemicals; research relating to chemistry; research relating to medicine; research relating to molecular sciences; research relating to pharmaceuticals; research relating to science; research to develop new products; services for assessing the efficiency of pharmaceuticals; services for assessing the safety of pharmaceuticals; chemical analysis; laboratory analysis; product analysis; analysis of tissues for medical research; design of medical apparatus; medical research laboratory services; analytical laboratory services; chemical laboratory services; laboratory research services; laboratory testing services; veterinary laboratory services; chemical research and analysis information; testing of chemicals; advisory, consultancy and information services for the foregoing. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 6, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 20, 2026 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 29, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 28, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |